Rapid and Sensitive Lentivirus Vector-based Conditional Gene Expression Assay to Monitor and Quantify Cell Fusion Activity
Overview
Affiliations
Cell-to-cell fusion is involved in multiple fundamental biological processes. Prominent examples include osteoclast and giant cell formation, fertilization and skeletal myogenesis which involve macrophage, sperm-egg and myoblast fusion, respectively. Indeed, the importance of cell fusion is underscored by the wide range of homeostatic as well as pathologic processes in which it plays a key role. Therefore, rapid and sensitive systems to trace and measure cell fusion events in various experimental systems are in demand. Here, we introduce a bipartite cell fusion monitoring system based on a genetic switch responsive to the site-specific recombinase FLP. To allow flexible deployment in both dividing as well as non-dividing cell populations, inducer and reporter modules were incorporated in lentivirus vector particles. Moreover, the recombinase-inducible transcription units were designed in such a way as to minimize basal activity and chromosomal position effects in the "off" and "on" states, respectively. The lentivirus vector-based conditional gene expression assay was validated in primary human mesenchymal stem cells and in a differentiation model based on muscle progenitor cells from a Duchenne muscular dystrophy patient using reporter genes compatible with live- and single-cell imaging and with whole population measurements. Using the skeletal muscle cell differentiation model, we showed that the new assay displays low background activity, a 2-log dynamic range, high sensitivity and is amenable to the investigation of cell fusion kinetics. The utility of the bipartite cell fusion monitoring system was underscored by a study on the impact of drug- and RNAi-mediated p38 MAPK inhibition on human myocyte differentiation. Finally, building on the capacity of lentivirus vectors to readily generate transgenic animals the present FLP-inducible system should be adaptable, alone or together with Cre/loxP-based assays, to cell lineage tracing and conditional gene manipulation studies in vivo.
Recombinant Porcine Interferon-α Decreases Pseudorabies Virus Infection.
Song B, Wei W, Liu X, Huang Y, Zhu S, Yi L Vaccines (Basel). 2023; 11(10).
PMID: 37896991 PMC: 10610829. DOI: 10.3390/vaccines11101587.
Huang C, Fang M, Xiao X, Gao Z, Wang Y, Gao C J Clin Lab Anal. 2022; 36(6):e24459.
PMID: 35470480 PMC: 9169201. DOI: 10.1002/jcla.24459.
Yuan L, Wu X, Li W, Zhuo C, Xu Z, Tan C Technol Cancer Res Treat. 2020; 19:1533033820983029.
PMID: 33356959 PMC: 7780307. DOI: 10.1177/1533033820983029.
Nassi J, Cepko C, Born R, Beier K Front Neuroanat. 2015; 9:80.
PMID: 26190977 PMC: 4486834. DOI: 10.3389/fnana.2015.00080.
Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model.
Pasetto S, Pardi V, Murata R PLoS One. 2014; 9(12):e115323.
PMID: 25546350 PMC: 4278898. DOI: 10.1371/journal.pone.0115323.